NCT06012435 2026-03-18
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Seagen Inc.
Phase 3 Active not recruiting
Seagen Inc.
AstraZeneca
Taiho Oncology, Inc.
AstraZeneca
H. Lee Moffitt Cancer Center and Research Institute